User profiles for Livia H. Yamashiro
Livia YamashiroUniversity of California-Berkeley Verified email at berkeley.edu Cited by 626 |
[HTML][HTML] Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection
…, X Nguyenla, E Van Dis, C Catamura, LH Yamashiro… - Nature …, 2022 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes a range of symptoms
in infected individuals, from mild respiratory illness to acute respiratory distress syndrome. …
in infected individuals, from mild respiratory illness to acute respiratory distress syndrome. …
[HTML][HTML] Interferon-independent STING signaling promotes resistance to HSV-1 in vivo
LH Yamashiro, SC Wilson, HM Morrison… - Nature …, 2020 - nature.com
The Stimulator of Interferon Genes (STING) pathway initiates potent immune responses upon
recognition of DNA. To initiate signaling, serine 365 (S365) in the C-terminal tail (CTT) of …
recognition of DNA. To initiate signaling, serine 365 (S365) in the C-terminal tail (CTT) of …
Type I interferon-driven susceptibility to Mycobacterium tuberculosis is mediated by IL-1Ra
DX Ji, LH Yamashiro, KJ Chen, N Mukaida… - Nature …, 2019 - nature.com
The bacterium Mycobacterium tuberculosis (Mtb) causes tuberculosis and is responsible for
more human mortality than any other single pathogen 1 . Progression to active disease …
more human mortality than any other single pathogen 1 . Progression to active disease …
[HTML][HTML] An intranasal ASO therapeutic targeting SARS-CoV-2
…, JZ Woo, L Xu, X Nguyenla, LH Yamashiro… - Nature …, 2022 - nature.com
The COVID-19 pandemic is exacting an increasing toll worldwide, with new SARS-CoV-2
variants emerging that exhibit higher infectivity rates and that may partially evade vaccine and …
variants emerging that exhibit higher infectivity rates and that may partially evade vaccine and …
Screening a library of FDA-approved and bioactive compounds for antiviral activity against SARS-CoV-2
…, E Van Dis, E Wehri, LH Yamashiro… - ACS infectious …, 2021 - ACS Publications
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The COVID…
coronavirus disease 2019 (COVID-19), has emerged as a major global health threat. The COVID…
[HTML][HTML] Antibiotic-induced pathobiont dissemination accelerates mortality in severe experimental pancreatitis
…, MR Valente, LKR Santos, LH Yamashiro… - Frontiers in …, 2017 - frontiersin.org
Although antibiotic-induced dysbiosis has been demonstrated to exacerbate intestinal
inflammation, it has been suggested that antibiotic prophylaxis may be beneficial in certain clinical …
inflammation, it has been suggested that antibiotic prophylaxis may be beneficial in certain clinical …
Genome-wide, bidirectional CRISPR screens identify mucins as critical host factors modulating SARS-CoV-2 infection
…, X Nguyenla, E Van Dis, C Catamura, LH Yamashiro… - BioRxiv, 2021 - biorxiv.org
SARS-CoV-2 can cause a range of symptoms in infected individuals, from mild respiratory
illness to acute respiratory distress syndrome. A systematic understanding of the host factors …
illness to acute respiratory distress syndrome. A systematic understanding of the host factors …
[HTML][HTML] Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells
SARS coronavirus 2 (SARS-CoV-2) has caused an ongoing global pandemic with significant
mortality and morbidity. At this time, the only FDA-approved therapeutic for COVID-19 is …
mortality and morbidity. At this time, the only FDA-approved therapeutic for COVID-19 is …
Cytokine-induced neutrophil chemoattractant (CINC)-1 induces fever by a prostaglandin-dependent mechanism in rats
Cytokine-induced neutrophil chemoattractant-1 (CINC-1), a member of the ELR+CXC
subfamily [ELR motif (glutamic acid-leucine-arginine) adjacent to the cysteine-X-cysteine (CXC) …
subfamily [ELR motif (glutamic acid-leucine-arginine) adjacent to the cysteine-X-cysteine (CXC) …
Isoniazid‐induced control of Mycobacterium tuberculosis by primary human cells requires interleukin‐1 receptor and tumor necrosis factor
LH Yamashiro, C Eto, M Soncini… - European Journal of …, 2016 - Wiley Online Library
Proinflammatory cytokines are critical mediators that control Mycobacterium tuberculosis (Mtb)
growth during active tuberculosis (ATB). To further inhibit bacterial proliferation in …
growth during active tuberculosis (ATB). To further inhibit bacterial proliferation in …